Healthcare
Glenmark Pharmaceuticals Limited
NSE: GLENMARK | Information Technology
₹2393.0
+0.59% Today
Market Fundamentals
Market Cap
₹67,531 Cr
P/E Ratio
N/A
Dividend Yield
0.00%
52W High
₹N/A
Stock Intelligence & News
NSE Online Announcements•2026-04-09
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled "Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg". |SUBJECT: Press Release
Read Full Analysis →Get instant alerts when GLENMARK breaks news
Join investors who track Glenmark Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for GLENMARK?
GLENMARK is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Glenmark Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding GLENMARK to your custom watchlist.